Helio Vision
Lexington
About Helio Vision
Helio Vision was founded in 2016 to develop a therapy for rare, fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The co-founders of Helio Vision, Massachusetts Eye and Ear Infirmary physicians Drs. Dean Eliott and Tomasz Stryjewski, have discovered that by using sustained intravitreal exposure to methotrexate, a medication with anti-proliferative and anti-inflammatory properties, this dreaded post-operative scarring cycle may be prevented.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $259.5K
- Funding stage: M&A
- Last round: Seed (Aug 2016)
- Website: heliovisioninc.com
- Phone: (617)647-0274
Industries & Categories
Biotechnology, Clinical Trials, Travel
Social Profiles
Canonical: https://fsome.com/organization/helio-vision-2253677 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.